Expression of Apoptosis-Related Proteins Is an Independent Determinant of Patient Prognosis in Advanced Ovarian Cancer
- 15 November 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (22) , 3775-3781
- https://doi.org/10.1200/jco.2000.18.22.3775
Abstract
PURPOSE: The present study was undertaken to investigate the prognostic and predictive relevance of the expression of apoptosis-related proteins Bax, Bcl-XL, and Mcl-1 in advanced ovarian cancer. P...Keywords
This publication has 27 references indexed in Scilit:
- Bcl-2 family proteinsOncogene, 1998
- Immunohistochemical Analysis of bc1–2, bax, mcl-1, and bc1-X Expression in Ovarian Surface Epithelial TumorsInternational Journal of Gynecological Pathology, 1998
- Bcl-xL forms an ion channel in synthetic lipid membranesNature, 1997
- Clinical multidrug resistance in cancer: A multifactorial problemEuropean Journal Of Cancer, 1996
- Apoptosis and chemotherapy resistanceEuropean Journal Of Cancer, 1996
- Life, death, and the pursuit of apoptosis.Genes & Development, 1996
- The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian CancerGynecologic Oncology, 1995
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958